The US Food and Drug Administration’s (FDA’s) new pathway for gene therapies could be “groundbreaking” if applied broadly, though the extent of its scope remains unclear. In a New England Journal of ...
Over the past 15 years scientists have identified hundreds of regions in the human genome associated with heart attack risk. However, efficient ways to explore how these genetic variants are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback